Synthesis And Characterization of New Heterocyclic Compounds and Anti-Cancer, Docking Study
Applied Chemical Engineering · 01.07.2026
DOI: 10.59429/ace.v9i3.5768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Chemical Engineering, online erschienen am 01.07.2026. Verfasst von HANOY K. AL-AMOOD und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Three new heterocyclic compounds, derivatives of hexahydropyrimidine (Py4M), thiazinam (Th4M), and oxazinan (OX4M), were synthesized through the reaction of substituted chalcone with guanidine hydrochloride, thiourea, and urea. Spectroscopic techniques such as FT-IR, mass spectrometry, and¹H NMR were used to characterize the synthesized compounds, confirming their proposed structures. The cytotoxicity of all synthesized compounds was evaluated in vitro using the MTT assay after 72 hours against the human breast cancer cell line MCF-7. The results demonstrated good activity of these compounds on MCF-7, particularly Th4M at a high concentration (1000 µg/ml), which showed an inhibition ratio of 76.9%. Three ligand-derived compounds (Py4M, OX4M, Th4M) were docked against MCF-7 breast cancer cells. Th4M exhibited the best binding affinity and potential anticancer activity.
Zitieren
APA
AL-AMOOD, H. K., AL-SHURAIFY, M. K., & SABAH, F. S. (2026). Synthesis And Characterization of New Heterocyclic Compounds and Anti-Cancer, Docking Study. Applied Chemical Engineering. https://doi.org/10.59429/ace.v9i3.5768
Vancouver
AL-AMOOD HK, AL-SHURAIFY MK, SABAH FS. Synthesis And Characterization of New Heterocyclic Compounds and Anti-Cancer, Docking Study. Applied Chemical Engineering. 2026. doi:10.59429/ace.v9i3.5768
BibTeX
@article{ALAMOOD2026,
author = {AL-AMOOD, HANOY K. and AL-SHURAIFY, MEAAD K. and SABAH, FATIMA S.},
title = {Synthesis And Characterization of New Heterocyclic Compounds and Anti-Cancer, Docking Study},
journal = {Applied Chemical Engineering},
year = {2026},
doi = {10.59429/ace.v9i3.5768}
}
EUVIMED